Sanofi Names David Meeker New CEO of Genzyme, Will Report to Viehbacher

Dr. Meeker will head Genzyme, now operating as a business unit of French pharmaceutical giant Sanofi, starting Nov. 1, 2011. He formerly served as Genzyme’s Chief Operating Officer. He will be heading the rare diseases and multiple sclerosis units, and report directly to Sanofi’s CEO Christopher Viehbacher.

Click here to read more.

Share this: